Tenaya Therapeutics Inc (NASDAQ:TNYA) has a beta value of 3.00 and has seen 0.5 million shares traded in the recent trading session. The company, currently valued at $112.25M, closed the recent trade at $0.69 per share which meant it gained $0.01 on the day or 1.01% during that session. The TNYA stock price is -488.41% off its 52-week high price of $4.06 and 47.83% above the 52-week low of $0.36. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.37 million shares traded. The 3-month trading volume is 2.32 million shares.
The consensus among analysts is that Tenaya Therapeutics Inc (TNYA) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.18.
Tenaya Therapeutics Inc (NASDAQ:TNYA) trade information
Sporting 1.01% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the TNYA stock price touched $0.69 or saw a rise of 4.81%. Year-to-date, Tenaya Therapeutics Inc shares have moved -77.52%, while the 5-day performance has seen it change 18.31%. Over the past 30 days, the shares of Tenaya Therapeutics Inc (NASDAQ:TNYA) have changed 9.19%. Short interest in the company has seen 11.89 million shares shorted with days to cover at 4.56.
Tenaya Therapeutics Inc (TNYA) estimates and forecasts
The company’s shares have lost -51.40% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -15.48% over the past 5 years.
TNYA Dividends
Tenaya Therapeutics Inc is expected to release its next earnings report on 2025-May-07 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Tenaya Therapeutics Inc (NASDAQ:TNYA)’s Major holders
Insiders own 0.72% of the company shares, while shares held by institutions stand at 59.67% with a share float percentage of 60.11%. Investors are also buoyed by the number of investors in a company, with Tenaya Therapeutics Inc having a total of 138.0 institutions that hold shares in the company. The top two institutional holders are COLUMN GROUP LLC with over 9.4 million shares worth more than $29.14 million. As of 2024-06-30, COLUMN GROUP LLC held 10.968% of shares outstanding.
The other major institutional holder is RA CAPITAL MANAGEMENT, L.P., with the holding of over 7.62 million shares as of 2024-06-30. The firm’s total holdings are worth over $23.63 million and represent 8.8935% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . As of Mar 31, 2025 , the former fund manager holds about 1.77% shares in the company for having 2.88 shares of worth $2.0 million while later fund manager owns 1.38 shares of worth $0.96 million as of May 31, 2025 , which makes it owner of about 0.85% of company’s outstanding stock.
